Le Lézard
Classified in: Science and technology
Subjects: Contract/Agreement, Product/Service

Denim Group Announces ThreadFix's Integration with UBsecure


Denim Group, the leading independent application security firm, today announced an integration with Japanese-based web application security company, UBsecure. This integration will allow UBsecure customers to generate .threadfix files through the company's web application security scanner, Vex, demonstrating Denim Group's commitment to supporting a broad range of enterprise-class application security integrations in their ThreadFix vulnerability management platform.

Within the application security space, there are a variety of security testing tools that all produce results in incompatible formats. The .threadfix file format provides a standardized method for scanning tools to communicate their results, gaining momentum as the de facto way to communicate between application security tools.

"We are excited to partner with Denim Group to continue helping our customers reduce their workloads and optimize the process of scanning websites and web applications," said President of UBsecure, Kotaro Kando. "By integrating the .threadfix file exporter into our Vex DAST scanner, we provide our customers with the ability to take advantage of the capabilities of the ThreadFix platform."

To add, through the integration with ThreadFix, UBsecure customers will be enabled to streamline their vulnerability management endeavors by consolidating their security testing results into a single unified view. The simplified view and risk-based filtering will also allow security teams to better prioritize vulnerabilities based on risk, giving them the outlook they need to identify and remediate the most serious vulnerabilities first.

"The UBsecure team has a rich understanding of vulnerability testing and the scenario creation methods for accurately detecting vulnerabilities," said CTO of Denim Group, Dan Cornell. "We look forward to integrating with UBsecure's Vex Vulnerability EXplorer to provide the industry with the most comprehensive vulnerability management platform that gives organizations a view of their risk from applications and their supporting infrastructure."

ThreadFix now integrates with over 50 different application scanners, network scanners and defect trackers to help organizations manage vulnerabilities from discovery to resolution. To learn more about Denim Group's integrations, visit our website here. Further information about the .threadfix file format can also be found here.

About Denim Group

Denim Group is the leading independent application security firm, serving as a trusted advisor to customers on matters of application risk and security. The company helps organizations assess and mitigate application security risk. Denim Group's flagship ThreadFix platform accelerates the process of application vulnerability remediation, reflecting the company's rich understanding of what it takes to fix application vulnerabilities faster.


These press releases may also interest you

at 21:30
Rubrik, Inc. today announced the pricing of its upsized initial public offering of 23,500,000 shares of its Class A common stock at a public offering price of $32.00 per share. In addition, Rubrik has granted the underwriters a 30-day option to...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:26
OKX, a leading Web3 technology company, has issued updates for April 24, 2024. OKX DeFi Launches 'zkSwap Bonus Event' Offering Users...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
The Board of Directors of TransAlta Corporation declared a quarterly dividend of $0.06 per common share payable on July 1, 2024 to shareholders of record at the close of business on June 1, 2024. The Board of Directors also declared the following...

at 21:02
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...



News published on and distributed by: